Epithelial intestine cells transdifferentiate into bladder urothelium in experiments in vivo

Tsitologiya

Volumn 53, Issue 4, 2011, Pages 332-340

  Popov, B V ^a   Zaichik, A M ^b   Budko, M B ^b   Zlobina, O V ^a   Tolkunova, E N ^a   Zhidkova, O V ^a   Petrov, N S ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b GOU DPO SPbMAPO Roszdrava   (Russian Federation)

Author keywords

Bladder urothelium; EGF and Wnt catenin signal pathways; Her 4 and Tcf3,4; Intestine epithelium; Transdifferentiation

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BETA CATENIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GREEN FLUORESCENT PROTEIN; TCF3 PROTEIN, MOUSE; TCF4 PROTEIN, MOUSE;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BLADDER; CELL TRANSDIFFERENTIATION; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; INJURY; INTESTINE; INTRALESIONAL DRUG ADMINISTRATION; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UROTHELIUM; WESTERN BLOTTING;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BETA CATENIN; BLOTTING, WESTERN; CELL TRANSDIFFERENTIATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; INTESTINES; MICE; MICE, TRANSGENIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HOMOLOGOUS; URINARY BLADDER; UROTHELIUM;

EID: 79961053091     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Russian source
2. Russian source
3. Anumanthan G., Makari J. H., Honea L., Thomas J. C., Wills M. L., Bhowmick N. A., Adams M. C., Hayward S. W., Matusik R. J., Brock J. W., 3rd, Pope J. C., 4th. 2008. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J. Urol. 180: 1778-1783.
4. Bajada S., Mazakova I., Richardson J. B., Ashammakhi N. 2008. Updates on stem cells and their applications in regenerative medicine. J. Tissue Eng. Regen. Med. 2: 169-183.
5. Barker N., van de Wetering M., Clevers H. 2008. The intestinal stem cell. Genes Develop. 22: 1856-1864.
6. Cooper E. H. 1972. The biology of bladder cancer. Ann. R. Coll. Surg. Engl. 51: 1-16.
7. De Coppi P., Callegari A., Chiavegato A., Gasparotto L., Piccoli M., Taiani J., Pozzobon M., Boldrin L., Okabe M., Cozzi E., Atala A., Gamba P., Sartore S. 2007. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J. Urol. 177: 369-376.
8. Haegebarth A., Clevers H. 2009. Wnt signaling, lgr5, and stem cells in the intestine and skin. Amer. J. Pathol. 174: 715-721.
9. Herzog E. L., Chai L., Krause D. S. 2003. Plasticity of marrow-derived stem cells. Blood. 102: 3483-3493.
10. Kastritis E., Murray S., Kyriakou F., Horti M., Tamvakis N., Kavantzas N., Patsouris E. S., Noni A., Legaki S., Dimopoulos M. A., Bamias A. 2009. Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication. Int. J. Cancer. 124: 103-108.
11. Kinebuchi Y., Johkura K., Sasaki K., Imamura T., Mimura Y., Nishizawa O. 2008. Direct induction of layered tissues from mouse embryonic stem cells: potential for differentiation into urinary tract tissue. Cell Tissue Res. 331: 605-615.
12. Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., Clevers H. 1998. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19: 379-383.
13. Kurzrock E. A., Lieu D. K., Degraffenried L. A., Chan C. W., Isseroff R. R. 2008. Label-retaining cells of the bladder: candidate urothelial stem cells. Amer. J. Physiol. Renal Physiol. 294: 1415-1421.
14. Nguyen H., Rendl M., Fuchs E. 2006. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell. 127: 171-183.
15. Nusse R., Fuerer C., Ching W., Harnish K., Logan C., Zeng A., ten Berge D., Kalani Y. 2008. Wnt signaling and stem cell control. Cold Spring Harbor. Symp. Quant. Biol. 73: 59-66.
16. Oottamasathien S., Wang Y., Williams K., Franco O. E., Wills M. L., Thomas J. C., Saba K., Sharif-Afshar A. R., Makari J. H., Bhowmick N. A., DeMarco R. T., Hipkens S., Magnuson M., Brock J. W., 3rd, Hayward S. W., Pope J. C., 4th, Matusik R. J. 2007. Directed differentiation of embryonic stem cells into bladder tissue. Develop. Biol. 304: 556-566.
17. Reya T., Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature. 434: 843-850.
18. Røtterud R., Nesland J. M., Berner A., Fossa S. D. 2005. Expression of the epidermal growth factor receptor family in normal and malignant urothelium. BJU Int. 95: 1344-1350.
19. Shukla D., Box G. N., Edwards R. A., Tyson D. R. 2008. Bone marrow stem cells for urologic tissue engineering. World J. Urol. 26: 341-349.
20. Southgate J., Harnden P., Trejdosiewicz L. K. 1999. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol. Histopathol. 14: 657-664.
21. Staack A., Hayward S. W., Baskin L. S., Cunha G. R. 2005. Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration. Differentiation. 73: 121-133.
22. Thomas J. C., Oottamasathien S., Makari J. H., Honea L., Sharif-Afshar A. R., Wang Y., Adams C., Wills M. L., Bhowmick N. A., Adams M. C., Brock J. W., 3rd, Hayward S. W., Matusik R. J., Pope J. C., 4th. 2008. Temporal-spatial protein expression in bladder tissue derived from embryonic stem cells. J. Urol. 180: 1784-1789.
23. Van der Flier L. G., Sabates-Bellver J., Oving I., Haegebarth A., De Palo M., Anti M., Van Gijn M. E., Suijkerbuijk S., Van de Wetering M., Marra G., Clevers H. 2007. The intestinal Wnt/TCF signature. Gastroenterology. 132: 628-632.
24. Van Es J. H., Clevers H. 2005. Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol. Med. 11: 496-502.
25. Varley C., Hill G., Pellegrin S., Shaw N. J., Selby P. J., Trejdosiewicz L. K., Southgate J. 2005. Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp. Cell Res. 306: 216-229.
26. Varley C. L., Stahlschmidt J., Lee W. C., Holder J., Diggle C., Selby P. J., Trejdosiewicz L. K., Southgate J. 2004a. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J. Cell Sci. 117: 2029-2036.
27. Varley C. L., Stahlschmidt J., Smith B., Stower M., Southgate J. 2004b. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Amer. J. Pathol. 164: 1789-1798.
28. Wu X. R., Lin J. H., Walz T., Häner M., Yu J., Aebi U., Sun T. T. 1994. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J. Biol. Chem. 269: 13 716-13 724.
29. Yu Z., Mannik J., Soto A., Lin K. K., Andersen B. 2009. The epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiation. EMBO J. 28: 1890-1903.